Antipsychotic Drug Reduction

NCAL extends assisted living quality campaign through 2018

NCAL extends assisted living quality campaign through 2018

By

Assisted living quality initiatives will focus on increasing satisfaction while reducing turnover, re-admissions and antipsychotics use, the National Center for Assisted Living announced on Tuesday.

Practical advice on reducing antipsychotics

Practical advice on reducing antipsychotics

Two CMS tags —F-Tag 329, which addresses unnecessarily using antipsychotic drugs, and F-Tag 309, which addresses taking steps to reduce antipsychotic drug use — are used by nursing home surveyors to identify specific federal nursing home regulations in order to evaluate whether a nursing home is meeting quality of care, quality of life, safety, among other standards.

New rankings might wrongly show downturn, leaders fear

New rankings might wrongly show downturn, leaders fear

By

Despite progress reducing off-label use of antipsychotics among nursing home residents, providers remained worried about a rebasing of the Centers for Medicare & Medicaid Services system to rank nursing homes.

Rate drops for antipsychotics

By

Industry leaders were pleasantly surprised to learn that nursing home operators had exceeded goals for lowering unnecessary antipsychotics use. The level dropped by nearly 20% over a three-year span.

GAO has good points in how, why antipsychotics are given

GAO has good points in how, why antipsychotics are given

By

The government recognizes the progress made in nursing homes with reduction of antipsychotics for residents with dementia, but also notes many who live in assisted living are receiving the drugs. It's part of a continuing narrative where the government is not super interested in paying for inappropriate medications that can harm seniors.

Assisted living residents with dementia receiving too many antipsychotics, GAO says

Assisted living residents with dementia receiving too many antipsychotics, GAO says

By

Government investigators are calling for greater scrutiny of antipsychotics use among dementia patients in post-acute settings beyond nursing homes.

IN2L announces study results

There was up to a 50% reduction in the use of psychotropic drugs when seniors in a continuing care retirement community received personalized technology services, according to research from It's Never 2 Late and Western Home Communities.

Drop in antipsychotics use surpasses providers' expectations

Drop in antipsychotics use surpasses providers' expectations

By

Leaders at the American Health Care Association said Monday they plan to keep the momentum going and further curb antipsychotic use in nursing homes after learning that a nearly 20% three-year decline exceeded their own expectations.

Reducing rehospitalizations and antipsychotics top-of-mind for long-term care providers at AHCA/NCAL convention

By

Developing effective relationships with hospitals begins by joining, initiating or hosting a cross continuum team at a long-term care provider's campus, an expert in senior care said Monday.

Creative activities for residents with dementia

Creative activities for residents with dementia

By

While conducting a training session last week in Montana, I was lucky enough to have a group of more than 100 staff members from various long-term care departments share some excellent suggestions on how to engage residents with dementia. They're too good to pass up.

Use caution in antipsychotics reduction

Use caution in antipsychotics reduction

By

It is true that I began speaking out about the misuse of antipsychotics drugs long before they came to national attention. But as I applaud the efforts of our providers and regulators around this important initiative, I would like to make two cautionary points.

Antipsychotics reduction goal raised to 30% by end of 2016, CMS and provider groups announce

Antipsychotics reduction goal raised to 30% by end of 2016, CMS and provider groups announce

By

Long-term care providers are being asked to reduce the use of antipsychotic medications among residents by 25% by the end of 2015, and 30% by the end of 2016. Providers have already achieved a 17.1% reduction since 2011.

Looking at dementia beyond drugs and disease

Looking at dementia beyond drugs and disease

The emerging literature on "nonpharmacological interventions" has not succeeded in providing long-term solutions for many people, such that expressions of need continue to recur on a regular basis.